# 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

> **NCT02786836** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 76 (actual)

## Conditions studied

- Acute Liver Failure

## Interventions

- **DRUG:** 13C-Methacetin

## Key facts

- **NCT ID:** NCT02786836
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-10
- **Primary completion:** 2019-09-18
- **Final completion:** 2019-09-18
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2020-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786836, "13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02786836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*